BrightGene Submits NDA for GLP-1R/GIPR Dual Agonist BGM0504 for Chronic Weight Management
Jun 11, 2026 12:26
CST Updated
12:55
Hengrui Pharma
Innovative and High-Quality Pharmaceutical Developer
Hansoh Pharma
Pharmaceutical Research, Production, and Sales